Creative Biolabs Announces Entry into AI-Powered Small Molecule Drug Design
Dec 28, 2022
New York City, New York Dec 28, 2022 (Issuewire.com) - In the past years, interest in adding artificial intelligence (AI) technology in drug research and development has greatly surged. Industrial reports have noted that signs of the impact of AI in small-molecule drug discovery so far are related to greater efficiency and accelerated timelines in early-stage research.
Creative Biolabs is one of the companies that believe AI can fulfill its broader promise to increase clinical success rates and reduce drug R&D costs and has established the innovative small molecule design and optimization service to deliver strategies and initiatives in an agile, rapid, and value-driven manner.
The expert team has gathered published usage data from journals, partners, and patents to generate a large, customized proprietary data set. And based on the database, AI, big data, and machine learning are combined to enhance the ability to computationally generate, screen, and optimize hundreds of millions of therapeutic small molecules.
The whole service pipeline will be open and transparent to make sure the clients can get access to the results of every step.
After learning details on the unique needs of clients, an appointed manager will lead an expert team to (1) extract the information about small molecules, drug design, and target diseases; (2) train computers to find a perfect AI algorithm in large databases; (3) calculating and identifying the most suitable small molecule for further evaluating and testing; (4) use multiple molecule parameters to train and optimize the bespoke AI algorithm; (5) improve the structure and properties of targeted small molecules aided by the optimized AI algorithm; (6) assess the synthetic process and tractability of small molecules.
The service is of great flexibility that clients can either custom a complete project covering design, optimization, and manufacturing, or adapt a single process to their specific project.
"We've taken a deep dive into AI for drug discovery, and established a deep learning method for achieving target recognition of small molecules drugs. These deep learning models have been proved to successfully predict the activity and properties of various small molecules," as introduced by a scientist at Creative Biolabs.
More information about AI solutions for drug development can be found at https://ai.creative-biolabs.com/.
About Creative Biolabs
Recognized as a reliable partner in antibody drug discovery and manufacturing serving academia and industry clients all over the world, Creative Biolabs has established an experimentally-certified AI platform, providing intelligent solutions to accelerate drug discovery and development covering antibody drugs and small molecule drugs. The AI solutions aim to help the pharma and biotechnology companies cut costs, streamline the workflow, and save valuable research time.
Source :Creative Biolabs
This article was originally published by IssueWire. Read the original article here.
More News
What’s In Anthropic’s I.P.O. Filing
The artificial intelligence giant reportedly believes that it’s on track for a record-breaking stock market listing, according to a prospectus seen by Reuters.
More free nursery hours proposed in budget
The government releases its proposed budget with "targeted measures" to help families.
Why Won’t My Co-Workers Acknowledge My Birthday?
Plus: What to do when your boss is nit-picking your work.
Warning more homes will be uninsurable due to flood risk
Aviva boss Amanda Blanc said England was "for sure" building homes that might be uninsurable at some point in the future.
OpenAI scraps rollout of new model over safety concerns
The firm also issued an update on incidents in which its models accessed Australian government systems.
UK tries to stop Trump's diesel export ban
John Healey said the government is in talks with the US over Donald Trump's threat to stop exports.
I paid £30,000 for an 'influencer' degree. Here's why
Content creation degrees aim to help people make money from social media, but are they worth the money?
Food waste charity gets grant for rising costs
The charity received a £60,000 grant, over three years, from Shrewsbury Town Council.
Apprentice star tells PM why pie shop is closing
Paul Bowen says a rise in employer's National Insurance was "the tipping edge" to him closing a pie shop.
Channel Islands fuel prices set to rise again
The increases could mean mean diesel costing more than £2 per litre.
US Hits Canada With Ban on Some Dairy and Liquor Products
An outright ban on certain Canadian products took effect Tuesday, escalating a damaging trade fight between the two North American allies.
For Japan’s Young Singles, Romance Gets a Corporate Middleman
A generation exhausted by dating apps is embracing a corporate reinvention of traditional matchmaking, fueling an industry that promises a fast track to marriage.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.